Fahar Merchant is the founder of Medicenna Therapeutics. Medicenna Therapeutics has raised $100M in total funding. Latest round: Growth. Backed by RA Capital.
Dr. Fahar Merchant is the President and CEO of Medicenna Therapeutics, a clinical-stage immunotherapy company focused on oncology and developing novel Superkines for treating various cancers. He has led the company through multiple financing rounds, raising over $100 million to advance its clinical programs.
Full founder directory · Investor directory · Company funding database · Fundraising library